^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
bleximenib (JNJ-6617)
i
Other names: JNJ-6617, JNJ 75276617, JNJ75276617, JNJ-75276617, JNJ6617, JNJ 6617
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
J&J
Drug class:
Menin-MLL inhibitor
Related drugs:
